Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era-Reference-Cited by-同舟云学术

Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

Published:2020-12-19 Issue:5 Volume:73 Page:e1222-e1227
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Guaraldi Giovanni¹^ORCID,Milic Jovana¹²,Martinez Esteban³,Kamarulzaman Adeeba⁴,Mussini Cristina¹,Waters Laura⁵,Pozniak Anton⁶,Mallon Patrick⁷,Rockstroh Jürgen K⁸,Lazarus Jeffrey V⁹^ORCID

Affiliation:

1. Modena HIV Metabolic Clinic (MHMC), Department of Surgical, Medical, Dental, and Morphological Sciences, University of Modena and Reggio Emilia, Italy

2. Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy

3. Infectious Diseases Unit, Hospital Clínic and University of Barcelona, Barcelona, Spain

4. Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

5. Mortimer Market Centre, Central & NW London NHS Trust, London, United Kingdom

6. Chelsea and Westminster Hospital NHS Foundation Trust and LSHTM, London, United Kingdom

7. University College Dublin Centre for Experimental Pathogen Host Research, Dublin, Ireland

8. Department of Medicine I, Bonn University Hospital, Bonn, Germany

9. Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain

Abstract

Abstract The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented global challenge that substantially risks reversing the progress in ending human immunodeficiency virus (HIV). At the same time, it may offer the opportunity for a new era of HIV management. This viewpoint presents the impact of COVID-19 on HIV care, including the Joint United Nations Programme on HIV/AIDS (UNAIDS) “three 90s” targets. It outlines how to enhance a patient-centered care approach, now known as the “fourth 90,” by integrating face-to-face patient–physician and telemedicine encounters. It suggests a framework for prevention and treatment of multimorbidity and frailty, to achieve a good health-related quality of life, and to preserve intrinsic capacity in all people living with HIV.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1864/36261998/ciaa1864.pdf

Reference27 articles.

1. HIV care in the COVID-19 era: a community perspective in collaboration with the European AIDS Treatment Group (EATG). In: HIV Glasgow—Virtual, 5–8 October 2020;von Lingen;J Intern AIDS Soc,2020

2. HIV care continuum and COVID-19 outcomes among people living with HIV during the COVID-19 pandemic, Chicago, IL;Ridgway;AIDS Behav,2020

3. Covid-19 and health care’s digital revolution;Keesara;N Engl J Med,2020

4. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort;Vizcarra;Lancet HIV,2020

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IAPAC–Lancet HIV Commission on the future of urban HIV responses;The Lancet HIV;2024-09

2. The Impact of COVID-19 on the HIV Cascade of Care in Botswana – An Interrupted Time Series;AIDS and Behavior;2024-06-10

3. Impact of the COVID-19 pandemic on mental health and viral suppression among persons living with HIV in western Washington;AIDS Care;2024-04-16

4. Impact of SARS-CoV-2/COVID-19 on HIV-1-associated neurocognitive disorders;HIV-Associated Neurocognitive Disorders;2024

5. The Interrelationship Between HIV Infection and COVID-19: A Review of the Literature;Current HIV Research;2023-12-27